“New data suggest that the risks associated with long-term, daily use of antibacterial soaps may outweigh the benefits,” Colleen Rogers, an FDA microbiologist, wrote in a statement on Monday.
Certain ingredients in such products – such as triclosan in liquid soaps and triclocarban in bar soaps – may contribute to bacterial resistance to antibiotics, the agency added.
Such products may also have “unanticipated hormonal effects that are of concern”, according to the statement.
Recent studies of such chemicals on animals have shown they may alter hormones, the FDA said, but such results have not yet been proven in humans.
“Because so many consumers use them, FDA believes that there should be clearly demonstrated benefits to balance any potential risks,” the statement added.
If the FDA’s proposed rule is finalised, companies would be required to provide data to support their product’s health claims.
If they cannot, the products would be reformulated or relabelled in order to remain on the market. …
Just use regular soap.